Analyze Diet
Mitochondrion2016; 30; 35-41; doi: 10.1016/j.mito.2016.06.005

Mitochondrial function is altered in horse atypical myopathy.

Abstract: Equine atypical myopathy in Europe is a fatal rhabdomyolysis syndrome that results from the ingestion of hypoglycin A contained in seeds and seedlings of Acer pseudoplatanus (sycamore maple). Acylcarnitine concentrations in serum and muscle OXPHOS capacity were determined in 15 atypical myopathy cases. All but one acylcarnitine were out of reference range and mitochondrial respiratory capacity was severely decreased up to 49% as compared to 10 healthy controls. The hallmark of atypical myopathy thus consists of a severe alteration in the energy metabolism including a severe impairment in muscle mitochondrial respiration that could contribute to its high death rate.
Publication Date: 2016-06-29 PubMed ID: 27374763DOI: 10.1016/j.mito.2016.06.005Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the alteration of mitochondrial function in horses due to atypical myopathy – a fatal condition often caused by consumption of toxins present in the seeds and seedlings of the sycamore maple tree.

About Atypical Myopathy and the Study

  • Atypical myopathy is a deadly muscle disease in horses, most prevalent in Europe. It often results from horses consuming hypoglycin A, a toxin found in the seeds and seedlings of the sycamore maple tree (Acer pseudoplatanus).
  • The focus of the study was to establish links between the disease and alterations in mitochondrial function – the part of cells responsible for generating most of their energy. This was carried out by examining serum and muscle Oxidative Phosphorylation System (OXPHOS) capacity in 15 horses diagnosed with atypical myopathy.

Key Findings

  • The study found that all but one of the acylcarnitine concentrations (metabolites involved in fat metabolism) in the horses were out of their typical range. This indicates a significant metabolic disruption in the affected horses.
  • In addition to this, the mitochondrial respiratory capacity – the ability of the mitochondria to produce energy – was significantly reduced, in some cases by up to 49% when compared to the 10 healthy control horses. This severe impairment suggests a potentially major role for mitochondrial dysfunction in the progression of atypical myopathy.

Conclusion

  • The research illustrates that atypical myopathy in horses is strongly associated with a severe alteration in energy metabolism, more specifically, a substantial impairment in muscle mitochondrial respiration. This finding could help explain why this condition has such a high mortality rate among affected horses.
  • Understanding this connection between the disease and mitochondrial function could potentially aid in developing more effective treatment and prevention strategies for equine atypical myopathy in the future.

Cite This Article

APA
Lemieux H, Boemer F, van Galen G, Serteyn D, Amory H, Baise E, Cassart D, van Loon G, Marcillaud-Pitel C, Votion DM. (2016). Mitochondrial function is altered in horse atypical myopathy. Mitochondrion, 30, 35-41. https://doi.org/10.1016/j.mito.2016.06.005

Publication

ISSN: 1872-8278
NlmUniqueID: 100968751
Country: Netherlands
Language: English
Volume: 30
Pages: 35-41

Researcher Affiliations

Lemieux, Hélène
  • Faculty Saint-Jean, University of Alberta, Edmonton, Alberta, Canada.
Boemer, François
  • Biochemical Genetics Laboratory, Human Genetics, CHU Liege, University of Liege, Belgium.
van Galen, Gaby
  • (c)Equine Clinic, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
Serteyn, Didier
  • (c)Equine Clinic, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium; Centre of Oxygen, Research and Development, University of Liege, Liege, Belgium.
Amory, Hélène
  • (c)Equine Clinic, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
Baise, Etienne
  • (e)Department of Animal Productions: Biostatistics, Economy and Animal Selection, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
Cassart, Dominique
  • Department of Pathology, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
van Loon, Gunther
  • (g)Large Animal Internal Medicine, Ghent University, Belgium.
Marcillaud-Pitel, Christel
  • (h)Réseau d'EpidémioSurveillance en Pathologie Equine (RESPE), Caen, France.
Votion, Dominique-M
  • (i)Equine Pole, Fundamental and Applied Research for Animals and Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium. Electronic address: dominique.votion@ulg.ac.be.

MeSH Terms

  • Acer / chemistry
  • Animal Feed
  • Animals
  • Carnitine / analogs & derivatives
  • Carnitine / blood
  • Europe
  • Female
  • Horse Diseases / chemically induced
  • Horse Diseases / pathology
  • Horses
  • Hypoglycins / toxicity
  • Male
  • Mitochondrial Diseases / chemically induced
  • Mitochondrial Diseases / pathology
  • Mitochondrial Diseases / veterinary
  • Muscles / pathology
  • Muscular Diseases / chemically induced
  • Muscular Diseases / pathology
  • Muscular Diseases / veterinary
  • Oxidative Phosphorylation

Citations

This article has been cited 7 times.
  1. François AC, Cesarini C, Taminiau B, Renaud B, Kruse CJ, Boemer F, van Loon G, Palmers K, Daube G, Wouters CP, Lecoq L, Gustin P, Votion DM. Unravelling Faecal Microbiota Variations in Equine Atypical Myopathy: Correlation with Blood Markers and Contribution of Microbiome. Animals (Basel) 2025 Jan 26;15(3).
    doi: 10.3390/ani15030354pubmed: 39943124google scholar: lookup
  2. Kruse CJ, Dieu M, Renaud B, François AC, Stern D, Demazy C, Burteau S, Boemer F, Art T, Renard P, Votion DM. New Pathophysiological Insights from Serum Proteome Profiling in Equine Atypical Myopathy. ACS Omega 2024 Feb 13;9(6):6505-6526.
    doi: 10.1021/acsomega.3c06647pubmed: 38371826google scholar: lookup
  3. Kruse CJ, Stern D, Mouithys-Mickalad A, Niesten A, Art T, Lemieux H, Votion DM. In Vitro Assays for the Assessment of Impaired Mitochondrial Bioenergetics in Equine Atypical Myopathy. Life (Basel) 2021 Jul 20;11(7).
    doi: 10.3390/life11070719pubmed: 34357091google scholar: lookup
  4. Hirz M, Gregersen HA, Sander J, Votion DM, Schänzer A, Köhler K, Herden C. Atypical myopathy in 2 Bactrian camels. J Vet Diagn Invest 2021 Sep;33(5):961-965.
    doi: 10.1177/10406387211020721pubmed: 34092152google scholar: lookup
  5. Maekawa S, Takada S, Furihata T, Fukushima A, Yokota T, Kinugawa S. Mitochondrial respiration of complex II is not lower than that of complex I in mouse skeletal muscle. Biochem Biophys Rep 2020 Mar;21:100717.
    doi: 10.1016/j.bbrep.2019.100717pubmed: 31890905google scholar: lookup
  6. Tosi I, Art T, Cassart D, Farnir F, Ceusters J, Serteyn D, Lemieux H, Votion DM. Altered mitochondrial oxidative phosphorylation capacity in horses suffering from polysaccharide storage myopathy. J Bioenerg Biomembr 2018 Oct;50(5):379-390.
    doi: 10.1007/s10863-018-9768-6pubmed: 30143916google scholar: lookup
  7. Lemieux H, Blier PU, Gnaiger E. Remodeling pathway control of mitochondrial respiratory capacity by temperature in mouse heart: electron flow through the Q-junction in permeabilized fibers. Sci Rep 2017 Jun 6;7(1):2840.
    doi: 10.1038/s41598-017-02789-8pubmed: 28588260google scholar: lookup